Wolfe Research initiated coverage on Johnson & Johnson with a new price target
$JNJ
Biotechnology: Pharmaceutical Preparations
Health Care
Wolfe Research initiated coverage of Johnson & Johnson with a rating of Outperform and set a new price target of $190.00